Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk.

Travis RC, Perez-Cornago A, Appleby PN, Albanes D, Joshu CE, Lutsey PL, Mondul AM, Platz EA, Weinstein SJ, Layne TM, Helzlsouer KJ, Visvanathan K, Palli D, Peeters PH, Bueno-de-Mesquita B, Trichopoulou A, Gunter MJ, Tsilidis KK, Sanchez MJ, Olsen A, Brenner H, Schöttker B, Perna L, Holleczek B, Knekt P, Rissanen H, Yeap BB, Flicker L, Almeida OP, Wong YYE, Chan JM, Giovannucci EL, Stampfer MJ, Ursin G, Gislefoss RE, Bjørge T, Meyer HE, Blomhoff R, Tsugane S, Sawada N, English DR, Eyles DW, Heath AK, Williamson EJ, Manjer J, Malm J, Almquist M, Le Marchand L, Haiman CA, Wilkens LR, Schenk JM, Tangen CM, Black A, Cook MB, Huang WY, Ziegler RG, Martin RM, Hamdy FC, Donovan JL, Neal DE, Touvier M, Hercberg S, Galan P, Deschasaux M, Key TJ, Allen NE.

Cancer Res. 2018 Nov 13. pii: canres.2318.2018. doi: 10.1158/0008-5472.CAN-18-2318. [Epub ahead of print]

PMID:
30425058
2.

Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies.

Watts EL, Appleby PN, Perez-Cornago A, Bueno-de-Mesquita HB, Chan JM, Chen C, Cohn BA, Cook MB, Flicker L, Freedman ND, Giles GG, Giovannucci E, Gislefoss RE, Hankey GJ, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luben RN, Luostarinen T, Männistö S, Metter EJ, Mikami K, Milne RL, Ozasa K, Platz EA, Quirós JR, Rissanen H, Sawada N, Stampfer M, Stanczyk FZ, Stattin P, Tamakoshi A, Tangen CM, Thompson IM, Tsilidis KK, Tsugane S, Ursin G, Vatten L, Weiss NS, Yeap BB, Allen NE, Key TJ, Travis RC.

Eur Urol. 2018 Nov;74(5):585-594. doi: 10.1016/j.eururo.2018.07.024. Epub 2018 Aug 1.

3.

Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls.

Perez-Cornago A, Appleby PN, Boeing H, Gil L, Kyrø C, Ricceri F, Murphy N, Trichopoulou A, Tsilidis KK, Khaw KT, Luben RN, Gislefoss RE, Langseth H, Drake I, Sonestedt E, Wallström P, Stattin P, Johansson A, Landberg R, Nilsson LM, Ozasa K, Tamakoshi A, Mikami K, Kubo T, Sawada N, Tsugane S, Key TJ, Allen NE, Travis RC.

Int J Cancer. 2018 Dec 1;143(11):2677-2686. doi: 10.1002/ijc.31640. Epub 2018 Sep 29.

4.

Author Correction: Large-scale intact glycopeptide identification by Mascot database search.

Bollineni RC, Koehler CJ, Gislefoss RE, Anonsen JH, Thiede B.

Sci Rep. 2018 Jun 22;8(1):9771. doi: 10.1038/s41598-018-28147-w.

5.

Vitamin D, obesity and leptin in relation to bladder cancer incidence and survival: prospective protocol study.

Gislefoss RE, Stenehjem JS, Hektoen HH, Andreassen BK, Langseth H, Axcrona K, Weiderpass E, Mondul A, Robsahm TE.

BMJ Open. 2018 Mar 30;8(3):e019309. doi: 10.1136/bmjopen-2017-019309.

6.

Large-scale intact glycopeptide identification by Mascot database search.

Bollineni RC, Koehler CJ, Gislefoss RE, Anonsen JH, Thiede B.

Sci Rep. 2018 Feb 1;8(1):2117. doi: 10.1038/s41598-018-20331-2. Erratum in: Sci Rep. 2018 Jun 22;8(1):9771.

7.

Sources to variability in circulating human miRNA signatures.

Keller A, Rounge T, Backes C, Ludwig N, Gislefoss R, Leidinger P, Langseth H, Meese E.

RNA Biol. 2017 Dec 2;14(12):1791-1798. doi: 10.1080/15476286.2017.1367888. Epub 2017 Sep 13.

8.

Cohort Profile Update: The Janus Serum Bank Cohort in Norway.

Hjerkind KV, Gislefoss RE, Tretli S, Nystad W, Bjørge T, Engeland A, Meyer HE, Holvik K, Ursin G, Langseth H.

Int J Epidemiol. 2017 Aug 1;46(4):1101-1102f. doi: 10.1093/ije/dyw302. No abstract available.

PMID:
28087783
9.

Effect of multiple freeze-thaw cycles on selected biochemical serum components.

Gislefoss RE, Lauritzen M, Langseth H, Mørkrid L.

Clin Chem Lab Med. 2017 Jun 27;55(7):967-973. doi: 10.1515/cclm-2016-0892.

PMID:
27987362
10.

Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014.

Andreassen BK, Aagnes B, Gislefoss R, Andreassen M, Wahlqvist R.

BMC Cancer. 2016 Oct 13;16(1):799.

11.

Cohort Profile: The Janus Serum Bank Cohort in Norway.

Langseth H, Gislefoss RE, Martinsen JI, Dillner J, Ursin G.

Int J Epidemiol. 2017 Apr 1;46(2):403-404g. doi: 10.1093/ije/dyw027. No abstract available.

PMID:
27063606
12.

Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls.

Price AJ, Travis RC, Appleby PN, Albanes D, Barricarte Gurrea A, Bjørge T, Bueno-de-Mesquita HB, Chen C, Donovan J, Gislefoss R, Goodman G, Gunter M, Hamdy FC, Johansson M, King IB, Kühn T, Männistö S, Martin RM, Meyer K, Neal DE, Neuhouser ML, Nygård O, Stattin P, Tell GS, Trichopoulou A, Tumino R, Ueland PM, Ulvik A, de Vogel S, Vollset SE, Weinstein SJ, Key TJ, Allen NE; Endogenous Hormones, Nutritional Biomarkers, and Prostate Cancer Collaborative Group.

Eur Urol. 2016 Dec;70(6):941-951. doi: 10.1016/j.eururo.2016.03.029. Epub 2016 Apr 6.

13.

Cutaneous Human Papillomaviruses and Squamous Cell Carcinoma of the Skin: Nested Case-Control Study.

Faust H, Andersson K, Luostarinen T, Gislefoss RE, Dillner J.

Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):721-4. doi: 10.1158/1055-9965.EPI-15-1290. Epub 2016 Feb 9.

14.

Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer.

Lumme S, Tenkanen L, Langseth H, Gislefoss R, Hakama M, Stattin P, Hallmans G, Adlercreutz H, Saikku P, Stenman UH, Tuohimaa P, Luostarinen T, Dillner J.

Acta Oncol. 2016 Jul;55(7):839-45. doi: 10.3109/0284186X.2016.1139178. Epub 2016 Feb 15.

PMID:
26878091
15.

HE4 as an Early Detection Biomarker of Epithelial Ovarian Cancer: Investigations in Prediagnostic Specimens From the Janus Serumbank.

Gislefoss RE, Langseth H, Bolstad N, Nustad K, Mørkrid L.

Int J Gynecol Cancer. 2015 Nov;25(9):1608-15. doi: 10.1097/IGC.0000000000000532.

PMID:
26501436
16.

microRNA Biomarker Discovery and High-Throughput DNA Sequencing Are Possible Using Long-term Archived Serum Samples.

Rounge TB, Lauritzen M, Langseth H, Enerly E, Lyle R, Gislefoss RE.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1381-7. doi: 10.1158/1055-9965.EPI-15-0289. Epub 2015 Jun 24.

17.

Stability of selected serum hormones and lipids after long-term storage in the Janus Serum Bank.

Gislefoss RE, Grimsrud TK, Mørkrid L.

Clin Biochem. 2015 Apr;48(6):364-9. doi: 10.1016/j.clinbiochem.2014.12.006. Epub 2014 Dec 16.

PMID:
25523301
18.

Prospective study of genital human papillomaviruses and nonmelanoma skin cancer.

Andersson K, Luostarinen T, Strand AS, Langseth H, Gislefoss RE, Forslund O, Pawlita M, Waterboer T, Dillner J.

Int J Cancer. 2013 Oct 15;133(8):1840-5. doi: 10.1002/ijc.28188. Epub 2013 Apr 25.

19.

Stability of testosterone measured in male archival serum samples by two different methods.

Gislefoss RE, Grimsrud TK, Høie K, Mørkrid L.

Scand J Clin Lab Invest. 2012 Nov;72(7):555-62. doi: 10.3109/00365513.2012.705888. Epub 2012 Aug 30.

PMID:
22935045
20.

Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer.

Andersson K, Michael KM, Luostarinen T, Waterboer T, Gislefoss R, Hakulinen T, Forslund O, Pawlita M, Dillner J.

Am J Epidemiol. 2012 Apr 1;175(7):685-95. doi: 10.1093/aje/kwr373. Epub 2012 Mar 14.

PMID:
22419740
21.

Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism.

Hustad S, Eussen S, Midttun Ø, Ulvik A, van de Kant PM, Mørkrid L, Gislefoss R, Ueland PM.

Clin Chem. 2012 Feb;58(2):402-10. doi: 10.1373/clinchem.2011.174490. Epub 2011 Dec 22.

22.

Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis.

Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, Staehler P, Lenhof HP, Meese E.

RNA Biol. 2011 May-Jun;8(3):506-16. Epub 2011 May 1.

PMID:
21558792
23.

Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study.

Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H.

Br J Cancer. 2010 May 25;102(11):1665-9. doi: 10.1038/sj.bjc.6605675. Epub 2010 Apr 20.

24.

Analytical recovery of folate and its degradation products in human serum stored at -25 degrees C for up to 29 years.

Hannisdal R, Gislefoss RE, Grimsrud TK, Hustad S, Mørkrid L, Ueland PM.

J Nutr. 2010 Mar;140(3):522-6. doi: 10.3945/jn.109.116418. Epub 2010 Jan 13.

PMID:
20071651
25.

Stability of selected serum proteins after long-term storage in the Janus Serum Bank.

Gislefoss RE, Grimsrud TK, Mørkrid L.

Clin Chem Lab Med. 2009;47(5):596-603. doi: 10.1515/CCLM.2009.121.

PMID:
19290843
26.

Long-term stability of serum components in the Janus Serum Bank.

Gislefoss RE, Grimsrud TK, Mørkrid L.

Scand J Clin Lab Invest. 2008;68(5):402-9. doi: 10.1080/00365510701809235.

PMID:
18752145
27.

Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors.

Jørgensen KT, Wiik A, Pedersen M, Hedegaard CJ, Vestergaard BF, Gislefoss RE, Kvien TK, Wohlfahrt J, Bendtzen K, Frisch M.

Ann Rheum Dis. 2008 Jun;67(6):860-6. Epub 2007 Jul 20.

PMID:
17644543
28.

No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus.

Lundstig A, Stattin P, Persson K, Sasnauskas K, Viscidi RP, Gislefoss RE, Dillner J.

Int J Cancer. 2007 Sep 1;121(5):1098-102.

29.

Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.

Pukkala E, Andersen A, Berglund G, Gislefoss R, Gudnason V, Hallmans G, Jellum E, Jousilahti P, Knekt P, Koskela P, Kyyrönen PP, Lenner P, Luostarinen T, Löve A, Ogmundsdóttir H, Stattin P, Tenkanen L, Tryggvadóttir L, Virtamo J, Wadell G, Widell A, Lehtinen M, Dillner J.

Acta Oncol. 2007;46(3):286-307.

PMID:
17450464
30.

Serum cotinine level as predictor of lung cancer risk.

Boffetta P, Clark S, Shen M, Gislefoss R, Peto R, Andersen A.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1184-8.

31.

Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk.

Tedeschi R, Luostarinen T, De Paoli P, Gislefoss RE, Tenkanen L, Virtamo J, Koskela P, Hallmans G, Lehtinen M, Dillner J.

Br J Cancer. 2005 Oct 3;93(7):834-7.

32.

Chlamydial antibodies and risk of prostate cancer.

Anttila T, Tenkanen L, Lumme S, Leinonen M, Gislefoss RE, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Stattin P, Saikku P, Dillner J, Lehtinen M, Hakama M.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):385-9.

33.
34.

BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study.

Bjørge T, Lie AK, Hovig E, Gislefoss RE, Hansen S, Jellum E, Langseth H, Nustad K, Tropé CG, Dørum A.

Br J Cancer. 2004 Nov 15;91(10):1829-34.

35.

Determination of hereditary mutations in the BRCA1 gene using archived serum samples and capillary electrophoresis.

Ekstrøm PO, Bjørge T, Dørum A, Longva AS, Heintz KM, Warren DJ, Hansen S, Gislefoss RE, Hovig E.

Anal Chem. 2004 Aug 1;76(15):4406-9.

PMID:
15283579
36.

Plasma leptin is not associated with prostate cancer risk.

Stattin P, Kaaks R, Johansson R, Gislefoss R, Söderberg S, Alfthan H, Stenman UH, Jellum E, Olsson T.

Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):474-5. No abstract available.

37.

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study.

Bjørge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E, Koskela P, Lehtinen M, Pukkala E, Thoresen SØ, Dillner J.

Br J Cancer. 2002 Jul 1;87(1):61-4. Erratum in: Br J Cancer. 2004 Sep 13;91(6):1226.

38.

Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein.

Engvig JP, Olsen KE, Gislefoss RE, Sletten K, Wahlström O, Westermark P.

Scand J Immunol. 1998 Jul;48(1):92-8.

39.

Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer.

Dillner J, Lehtinen M, Björge T, Luostarinen T, Youngman L, Jellum E, Koskela P, Gislefoss RE, Hallmans G, Paavonen J, Sapp M, Schiller JT, Hakulinen T, Thoresen S, Hakama M.

J Natl Cancer Inst. 1997 Sep 3;89(17):1293-9.

PMID:
9293920
40.

Diagnostic applications of chromatography and capillary electrophoresis.

Jellum E, Dollekamp H, Brunsvig A, Gislefoss R.

J Chromatogr B Biomed Sci Appl. 1997 Feb 7;689(1):155-64.

PMID:
9061490

Supplemental Content

Loading ...
Support Center